Cargando…
Risk of hepatocellular carcinoma after HCV eradication: Determining the role of portal hypertension by measuring spleen stiffness
BACKGROUND & AIMS: Hepatitis C virus (HCV) eradication with direct-acting antivirals (DAAs) reduces but does not eliminate the risk for hepatocellular carcinoma (HCC). The development of surveillance strategies for HCC after the sustained virologic response (SVR) is therefore warranted. We aimed...
Autores principales: | Dajti, Elton, Marasco, Giovanni, Ravaioli, Federico, Colecchia, Luigi, Ferrarese, Alberto, Festi, Davide, Colecchia, Antonio |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Elsevier
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8165428/ https://www.ncbi.nlm.nih.gov/pubmed/34095798 http://dx.doi.org/10.1016/j.jhepr.2021.100289 |
Ejemplares similares
-
Liver and Spleen Stiffness Measurements for Assessment of Portal Hypertension Severity in Patients with Budd Chiari Syndrome
por: Dajti, Elton, et al.
Publicado: (2019) -
Spleen stiffness mirrors changes in portal hypertension after successful interferon-free therapy in chronic-hepatitis C virus patients
por: Ravaioli, Federico, et al.
Publicado: (2018) -
Non-invasive tests for the prediction of primary hepatocellular carcinoma
por: Marasco, Giovanni, et al.
Publicado: (2020) -
Clinical Presentation of Celiac Disease and Diagnosis Accuracy in a Single-Center European Pediatric Cohort over 10 Years
por: Di Biase, Anna Rita, et al.
Publicado: (2021) -
Sarcopenia Predicts Major Complications after Resection for Primary Hepatocellular Carcinoma in Compensated Cirrhosis
por: Marasco, Giovanni, et al.
Publicado: (2022)